Moderna, Inc. (MRNA)
39.83
+0.23
(+0.58%)
USD |
NASDAQ |
Jan 14, 12:18
Moderna Market Cap: 15.56B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 957.12B |
| Merck & Co., Inc. | 272.23B |
| Pfizer Inc. | 145.16B |
| Novavax, Inc. | 1.302B |
| Johnson & Johnson | 524.84B |
Market Cap Related Metrics
| PS Ratio | 6.911 |
| PEG Ratio | -0.1284 |
| Price to Book Value | 1.668 |
| Price | 39.83 |
| Earnings Yield | -20.25% |
| PEGY Ratio | -0.1284 |